Disclosures: GCT is employed by Bristol-Myers Squibb. All other authors declare no conflict of interest.
Increased serum insulin-like growth factor-1 levels are associated with prolonged response to dasatinib-based regimens in metastatic prostate cancer†
Article first published online: 31 JAN 2013
Copyright © 2013 Wiley Periodicals, Inc.
Volume 73, Issue 9, pages 979–985, June 2013
How to Cite
Dayyani, F., Varkaris, A., Araujo, J. C., Song, J. H., Chatterji, T., Trudel, G. C., Logothetis, C. J. and Gallick, G. E. (2013), Increased serum insulin-like growth factor-1 levels are associated with prolonged response to dasatinib-based regimens in metastatic prostate cancer. Prostate, 73: 979–985. doi: 10.1002/pros.22645
- Issue published online: 25 MAY 2013
- Article first published online: 31 JAN 2013
- Manuscript Accepted: 8 JAN 2013
- Manuscript Received: 26 OCT 2012
- NIH. Grant Numbers: P50 CA140388-03, P50 CA140388-01
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.